Difference between revisions of "ATP2C2-AS1"

From LncRNAWiki
Jump to: navigation, search
Line 2: Line 2:
 
==Annotated Information==
 
==Annotated Information==
 
===Name===
 
===Name===
−
ATP2C2-AS1:ATP2C2 antisense RNA 1
+
Approved symbol: ATP2C2-AS1:ATP2C2 antisense RNA 1
  
−
RP11-517C16.2-001 <ref name="ref1" />
+
Alias symbols : RP11-517C16.2-001 <ref name="ref1" />, RP11-517C16.2
  
 +
HGNC ID : HGNC:53167
 +
 +
LncBook transcript ID: HSALNT0289472
 +
 +
===Characteristics===
 +
-
 +
===Function===
 +
 +
===Regulation===
 +
-
 +
===Diseases
 +
-
 
===Expression===
 
===Expression===
 
RP11-517C16.2-001 is significantly upregulated (33.479-fold) in Botulinum Toxin Type A (BoNTA )(5 U 48 h) treated human dermal fibroblasts <ref name="ref1" />.
 
RP11-517C16.2-001 is significantly upregulated (33.479-fold) in Botulinum Toxin Type A (BoNTA )(5 U 48 h) treated human dermal fibroblasts <ref name="ref1" />.
 +
 +
==Labs working on this lncRNA==
 +
*Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
 +
==References==
 +
<references>
 +
<ref name="ref1">
 +
Miao YY, Liu J, Zhu J, Tao YL, Zhang JA, Luo D, Zhou BR. The Effect of
 +
Botulinum Toxin Type A on Expression Profiling of Long Noncoding RNAs in Human
 +
Dermal Fibroblasts. Biomed Res Int. 2017;2017:2957941. doi:10.1155/2017/2957941.
 +
</ref>(1)
 +
</references>
  
 
===Sequence===
 
===Sequence===
Line 54: Line 77:
 
CTCTGCGCCGGTGGCCCATCCATGATGATGTTGATCCATAGGATCTGCATGGCGTTGAGGGGGCTGGGCA
 
CTCTGCGCCGGTGGCCCATCCATGATGATGTTGATCCATAGGATCTGCATGGCGTTGAGGGGGCTGGGCA
 
GGTTGAACACGGTGGACAGAGTGATGAGACTCAGGGCGGAGATGCTCCTGCGGGGCAC</dnaseq>
 
GGTTGAACACGGTGGACAGAGTGATGAGACTCAGGGCGGAGATGCTCCTGCGGGGCAC</dnaseq>
−
 
−
==Labs working on this lncRNA==
 
−
*Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
 
−
==References==
 
−
<references>
 
−
<ref name="ref1">
 
−
Miao YY, Liu J, Zhu J, Tao YL, Zhang JA, Luo D, Zhou BR. The Effect of
 
−
Botulinum Toxin Type A on Expression Profiling of Long Noncoding RNAs in Human
 
−
Dermal Fibroblasts. Biomed Res Int. 2017;2017:2957941. doi: 10.1155/2017/2957941.
 
−
Epub 2017 Feb 7.
 
−
</ref>
 
−
</references>
 

Revision as of 13:24, 6 August 2019

Annotated Information

Name

Approved symbol: ATP2C2-AS1:ATP2C2 antisense RNA 1

Alias symbols : RP11-517C16.2-001 [1], RP11-517C16.2

HGNC ID : HGNC:53167

LncBook transcript ID: HSALNT0289472

Characteristics

-

Function

Regulation

- ===Diseases -

Expression

RP11-517C16.2-001 is significantly upregulated (33.479-fold) in Botulinum Toxin Type A (BoNTA )(5 U 48 h) treated human dermal fibroblasts [1].

Labs working on this lncRNA

  • Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

References

  1. ↑ 1.0 1.1 Miao YY, Liu J, Zhu J, Tao YL, Zhang JA, Luo D, Zhou BR. The Effect of Botulinum Toxin Type A on Expression Profiling of Long Noncoding RNAs in Human Dermal Fibroblasts. Biomed Res Int. 2017;2017:2957941. doi:10.1155/2017/2957941.

Sequence

>NR_146503.1 Homo sapiens ATP2C2 antisense RNA 1 (ATP2C2-AS1), long non-coding RNA

000001 ATCAGAAGGC CTGGGCAGAC TTGGCCAGCC ACCTGGAGCA CTGTGCCCTT AAACTCAGGG CATTCACTGG TGACCCACAC 000080
000081 TGACACTGCT TTTTGGAGGA CAAGGCAGAG TTGACCATCC CAGTCTTGCC TGGAGGTCAT AGGACCGTTG TCACTGCAGC 000160
000161 CTCAGGTCTG ATGCATAATC CCATGACCCT CCAGATCTGA GCCATGACCC ACTCTGGGCC CTGCCGGCGG GGAGGCGGTG 000240
000241 GGCCCATGGG GGCTGCCTCA CTGGCCTCCC TCGTCCTCTA TTCCGGGTTG GGGTTGGCTC TCAGCACACT GGGGAAAAGG 000320
000321 GTGGGGTCGA TGACTTGTCC CTGGCTCCCT CCCCTTGCCC CATGCCTGCC ATAACCGCAG CTTCAGAGAA AGGTGCCACA 000400
000401 CTCGCTTGGC TGACAATGTC GGGGAGTCCC CTGGGCTCCA CACCAGGGCG TGTGCCCTTG GAAAACCACG GTGACTGAAT 000480
000481 CATGTCCCTT TCAGCCAAAA CTGGAAGACA GCCCAGCTCC CTGCCTTCAG GTGACCAGAT CTCTAAGTCA CATTACTGGC 000560
000561 CCCAGGGTCA AGTCCAGGCT CCCCAGCTGG GGTACCTCCC AGGCTGAGTA CAGGCCTTGC TCCCTCCTTC CTCCCTGCAC 000640
000641 GTGCTCTGAG CCTCCAGCCC GACGCCTGGG ATGCCGGTGC CCCTTGGGCC CCAGACCCTA CTACTCTTGA GTGACAGGCC 000720
000721 TCTTCCTAGG GGTTTCTGTG CATCCGTCAC ATCACCCACG TTAGAGTCCC TTCCTGTGAG GACAGAAGGG CCCTGAAGAC 000800
000801 AGAGCCGGCC CCTGGTGAGC TCTGCTTTCC CGCACTGACC CCTCCTGGGC TGCAGCTCCC CACCTGGCAG CTGCCGCCCC 000880
000881 CCATGGCCCT GGTCGAGGTC ACCTGTCGTT CCCGTCCCCA CCACTCACCA AGCGCTCCCA GGTTCTCCGT CTGGAAGACC 000960
000961 CTCTGCAGCG GGGGGATGTA AATGACCGCC AGCTGCCCCA GGATGGACCC CAGGACGGAG TAGAGGAACA TGTGGTTCCT 001040
001041 GAGAAAGCCG ATCTCAAATA TCAGCTTGGT CTGCAGGGAG AAGGTCACAC GGGGGATTGT GTGCTGTCCA CACCCCAGGT 001120
001121 ACAGGCAGGG GAGCTCTGAC TGCCCACGCT GAGCCAGAGC CGCTCAATGC TGCGGGCAGG GTCGGGGCGC TGCTGTCGAG 001200
001201 AACACACAGC AGCTCTGCAG CGAGGAGGGT CAGCCCGGGT CTCACCTGAG AGCGGCAGGT CAAGGCGTTG AAGAGATCGA 001280
001281 AAAACACAAA ACAAGTGAAC GTCATCGTCG TGGTGCGGGG AGTGCTTGCT CTGTCTTCAG GCATCTGGAA GGTGAGCACA 001360
001361 AAGATGTGAG CTGTGGCAGG AGGGCAGGGA CTGCAGTCCC CAGCGTCTGC ACCGCACCAG GGCTTGGAGA ACAGGCCGGG 001440
001441 GTGACCCTCG CTCACCTCCT TCCAGAAGAT AAAGAGGGTC CCGCTGATGA TGATGGCCGC GGACATGAGG ATCTTCAGGA 001520
001521 TGAGGGCTCT GCTGAGGATG GTGTCCCGCA CACTCCGTGG TGGCTGCCTG AAGGCGTCTT TGTCAACGGG CTCTACCCCC 001600
001601 AAGCTGCTCC GAACAAGACA CAGACACTTT GAAATGAACC AGGAATGAAA TAAAGGACCC TTGAAACAGC TGTGCCTGAG 001680
001681 CCTCCCAGGC CAAGTTGGCA CAGGGGGCAG GGCCAGGCAT TTGCTGAACG CCCCCAGGCA TCGCACCTGC CCTCCTCGGC 001760
001761 ACCTTCCAGA AGCCCCAGAG CCTGGGTCCA TGGGCAGCTG TGCCCCTCCA TCTGTCCCGC AGACAGTGAA GGAAGACCAC 001840
001841 CCCGTAAGGC CAACCACACA CAGTTCCATA CACCCAGATG ATCTCCATCA CCCCGAGGGG ACCCCCCCCA ACGTTGC